Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Maintains Buy on Datadog, Raises Price Target to $105

Needham Maintains Buy on Datadog, Raises Price Target to $105

Needham analyst Mike Cikos maintains Datadog (NASDAQ:DDOG) with a Buy and raises the price target from $90 to $105.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Needham analyst Mike Cikos maintains Datadog (NASDAQ:DDOG) with a Buy and raises the price target from $90 to $105.

Performance Food Group Q3: EPS Beat, Topline Miss, Solid Cash Flow & More

By Shivani Kumaresan

May 10, 11:16 AM

Performance Food Group Co (NYSE:PFGC) reported third-quarter FY23 sales growth of 5% year-on-year to $13.77 billion, missing the consensus of $13.90…

PFGC

Analyst Ratings

Expert Ratings for Snowflake

By Benzinga Insights

August 14, 1:00 PM

Over the past 3 months, 36 analysts have published their opinion on Snowflake (NYSE:SNOW) stock. These analysts are…

SNOW

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

September 20, 2:10 PM

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

ADD

Ironwood’s Constipation Drug Shows Efficacy In Pediatric Patients

By Vandana Singh

September 6, 9:26 AM

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) announced topline data from a Phase 3 trial evaluating Linzess (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation.

ABBV

Needham Maintains Buy on Datadog, Raises Price Target to $105

Related Posts

Performance Food Group Q3: EPS Beat, Topline Miss, Solid Cash Flow & More

Expert Ratings for Snowflake

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Ironwood’s Constipation Drug Shows Efficacy In Pediatric Patients